[ASND] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
23-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -52.84%
YoY- -22.52%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 2,225 5,414 28 372 1,258 2,081 3,994 -9.28%
PBT -63,394 -53,707 -41,482 -25,153 -20,636 1,468 -498 124.12%
Tax -77 -70 -107 -14 -118 46 4 -
NP -63,317 -53,637 -41,375 -25,139 -20,518 1,422 -502 123.77%
Tax Rate - - - - - -3.13% - -
Total Cost 65,542 59,051 41,403 25,511 21,776 659 4,496 56.23%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -2,845.71 -990.71 -147,767.86 -6,757.80 -1,631.00 68.33 -12.57 146.67%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -1.32 -1.24 -1.07 -0.78 -0.82 0.07 -0.05 72.47%
EPS Diluted -1.32 -1.24 -1.07 -0.78 -0.82 0.06 -0.05 72.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.